BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Immunic Inc.

Headquarters: New York, NY, United States of America
Year Founded: 2016
Status: Public
Industry Sector: HealthTechnology
CEO: Daniel Vitt, PhD
Number Of Employees: 77
Enterprise Value: $21,140,075
PE Ratio: -0.9
Exchange/Ticker 1: NASDAQ:IMUX
Exchange/Ticker 2: N/A
Latest Market Cap: $100,888,496

BioCentury | Jul 10, 2024
Management Tracks

Promotions for Flagship’s Afzelius, Biondi come amid $3.6B raise

Plus: EveryONE names CEO and chairman and updates from Lunit, Quell, ImCheck, Aktis, Immunic and Curve
BioCentury | Feb 20, 2024
Distillery Therapeutics

Inhibiting epithelial SIRT6 for asthma

BioCentury | Jan 6, 2024
Finance

Jan. 5 Quick Takes: Metagenomi, ArriVent file for IPO

Plus: Immunic eyes $240M private placement and updates from Applied Therapeutics and Novartis  
BioCentury | Oct 21, 2022
Politics, Policy & Law

Oct. 20 Quick Takes: Novartis commits first cancer therapy to UN patent pool

Plus: AbbVie gains LPAR1 antibody via $255M buy of DJS and updates for Denali, the U.K., Kite-Refuge, Takeda-Zedira, Immunic, Talaris, Celeris
BioCentury | Jun 3, 2022
Deals

June 2 Quick Takes: BMS, Immatics expand partnership to allogeneic T cells

Plus Transition’s $50M A round, Centessa’s killed kidney program and updates from Centessa, Aeglea, Immunic and more
BioCentury | Mar 17, 2022
Management Tracks

Denali co-founder, COO Schuth to take on CFO role

Plus Immunic promotes Whaley to CFO and updates from Mablink, Agendia, SNIPR and more
BioCentury | Oct 15, 2021
Management Tracks

Malek joins NIBR as head of oncology disease area

Plus: Translate Bio vet Smith joins CRISPR as CFO and updates from Travere, Kojin, AMO, Poseida, Synairgen and more
BioCentury | May 15, 2020
Product Development

Repurposed autoimmune therapies head for controlled COVID-19 studies in Europe

Plus USPTO to fast-track patent reviews, and a social distancing tool for the lab and office
Items per page:
1 - 10 of 19